GlassScriptPhysician profile
Douglas M Addy
NPI 1942270590
$5,638.20
in general payments reported to CMS, 2019-2025
33 companies · $606 in 2025
The $606 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,754 · 2020: $198 · 2021: $16.16 · 2022: $655 · 2023: $808 · 2024: $601 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,996 · Education: $18.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,995.98 |
| Education | $18.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,680.24 | 2019-2025 | Da Vinci Surgical System |
| Abbvie INC. | $360.36 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Coopersurgical, INC. | $264.33 | 2019-2025 | Ally II Ups, Paragard T 380a |
| Daiichi Sankyo INC. | $261.09 | 2019-2025 | Injectafer |
| Sumitomo Pharma America, INC. | $224.29 | 2023-2025 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $214.18 | 2019-2025 | |
| Astellas Pharma US INC | $187.09 | 2023-2025 | Veozah |
| Conmed Corporation | $143.07 | 2022-2024 | Conmed Trocars |
| Exeltis, USA INC. | $135.88 | 2023-2025 | Slynd |
| Sage Therapeutics, LLC | $128.05 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $127.73 | 2022-2025 | |
| Shield Therapeutics INC | $96.39 | 2022-2024 | Accrufer |
| Optumhealth Care Solutions, LLC | $85.83 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Therapeuticsmd, INC. | $85.67 | 2019-2022 | |
| Myovant Sciences INC. | $73.79 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $72.60 | 2023 | Ligasure |
| Organon LLC | $64.27 | 2022-2025 | Nexplanon |
| Meditrina | $52.46 | 2023 | |
| Amag Pharmaceuticals, INC. | $49.91 | 2019 | |
| Inari Medical, INC. | $49.67 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Exact Sciences Corporation | $42.91 | 2023 | Cologuard Collection Kit |
| Mylan Pharmaceuticals INC. | $36.87 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $31.25 | 2022-2023 | Exparel |
| Kedrion Biopharma, INC. | $24.76 | 2025 | Albuked, Rhogam Ultra-Filtered Plus, Koate |
| Aspira Women'S Health INC | $19.57 | 2023 | Ova1 |
| Acessa Health INC. | $19.35 | 2019 | |
| Agile Therapeutics, INC. | $18.01 | 2023 | Twirla |
| Avion Pharmaceuticals | $16.85 | 2019 | |
| Mayne Pharma Commercial LLC | $16.57 | 2025 | |
| Vertical Pharmaceuticals, LLC | $16.29 | 2019 | |
| Innovation Technologies INC | $15.07 | 2025 | Irrisept |
| Hologic Sales and Service, LLC | $14.08 | 2022 | |
| Channel Medsystems, INC. | $9.72 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Addy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.